HEMOSTASIS COAGULATION ROUTINE INHIBITOR NIJMEGEN BETHESDA ASSAYS FVIII INHIBITOR NIJMEGEN BETHESDA CONTROLS
Factor VIII Inhibitor Plasma Weak Control
Nijmegen Bethesda Controls
Factor VIII deficient plasma without Factor VIII inhibitor.
This plasma can be used for the control of the determination of Factor VIII (FVIII) inhibitor according to the Bethesda assays or modified Nijmegen Bethesda assays.
Factor VIII Inhibitor Plasma Weak Control is made from a pool of Factor VIII deficient (<1%) human plasma.
It contains a specific natural inhibitor directed against the activity of Factor VIII (FVIII).
Reference | 6-1800-05 |
---|---|
Presentation | Vial |
Format | 25 x 0.5 mL |
Quote |
Price list, safety data sheets and notices are accessible to our registered customers.
Reference | Presentation | Format | Quote | Product sheet |
---|---|---|---|---|
6-1800-05 | Vial | 25 x 0.5 mL |